Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat.
Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into people. Many scientists believe that is how the COVID-19 pandemic began, with SARS-CoV-2, the virus responsible for COVID-19, originating from a family of coronaviruses found in bats.
Now, researchers from the UCSF Quantitative Biosciences Institute, Icahn School of Medicine at Mount Sinai, Institut Pasteur, and Fred Hutchinson Cancer Center have uncovered evidence that a single amino acid change in a coronavirus protein can dramatically alter how the virus interacts with the immune systems of bats and humans. Their findings offer new insight into how an otherwise harmless animal virus can evolve into one capable of causing serious disease in people.
The research was published in Cell Host & Microbe.
A Tiny Genetic Difference With a Big Impact
To investigate what allows some coronaviruses to infect humans, the team compared SARS-CoV-2 with a closely related bat coronavirus called RaTG13, which infects bats but is not known to infect people. Using the first laboratory-grown lung cell line developed from the greater horseshoe bat, the researchers examined how each virus interacted with immune proteins in both bat and human lung cells.
One viral protein, known as OrfB9, stood out. The SARS-CoV-2 and RaTG13 versions of OrfB9 differ by just one amino acid out of roughly 100, yet that tiny difference had striking effects.
In human lung cells, the SARS-CoV-2 version of OrfB9 shut down an important immune alarm system, allowing the virus to replicate more easily. In bat lung cells, the RaTG13 version had the opposite effect, activating an immune protein that helped keep the virus under control.
Clues to How Viruses Cross Species
The discovery highlights how even the smallest genetic changes can influence whether a virus remains confined to animals or gains the ability to infect humans.
"The difference between a virus that stays in bats and one that spills over into humans and causes catastrophic disease can come down to remarkably small genetic changes," said Nevan J. Krogan, PhD, director of QBI and senior author of the study. "By mapping these interactions at the protein level — across two viruses and two species — we can read the molecular signatures that predict spillover risk. It's the kind of early warning system the world needs."
By identifying the molecular changes that alter interactions between viruses and the immune system, the researchers hope their work will improve scientists' ability to recognize animal viruses with the greatest potential to spill over into humans before they spark future outbreaks.
Reference: "Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential" by Jyoti Batra, Magdalena Rutkowska, Yuan Zhou, Chengjin Ye, Rithika Adavikolanu, Janet M. Young, Durga Anand, Sooraj Verma, Haripriya Parthasarathy, Martin Gordon, Shivali Malpotra, Anastasija Cupic, Thomas Kehrer, Melanie Dos Santos, Ronald Benjamin, Jack M. Moen, Declan M. Winters, Vincent Caval, Ajda Rojc, Ignacio Mena, Sadaf Aslam, Carles Martinez-Romero, Isabela Conde Viñas, Zain Khalil, Keith Farrugia, Fernando Villalón-Letelier, Atoshi Banerjee, Dafna Tussia-Cohen, Amy Diallo, Sourobh Maji, Monita Muralidharan, Helene Foussard, Irene P. Chen, Rotem Fuchs, C.J. San Felipe, Lorena Zuliani-Alvarez, Promisree Choudhury, Kirsten Obernier, Ségolène Gracias, Rahul K. Suryawanshi, Boris Bonaventure, Carlos Ibáñez, Jeffrey R. Johnson, Javier Juste, Lars Pache, Robert M. Stroud, Kliment A. Verba, James S. Fraser, Harm van Bakel, Taha Y. Taha, Melanie Ott, Tzachi Hagai, Nolwenn Jouvenet, Caroline Demeret, Benjamin J. Polacco, Danielle L. Swaney, Ignacia Echeverria, Mehdi Bouhaddou, Manon Eckhardt, Harmit S. Malik, Luis Martinez-Sobrido, Lisa Miorin, Adolfo García-Sastre and Nevan J. Krogan, 13 May 2026, Cell Host & Microbe.
DOI: 10.1016/j.chom.2026.04.015
Authors: UCSF authors are Jyoti Batra, PhD; Yuan Zhou, MS; Rithika Adavikolanu; Durga Anand; Sooraj Verma; Martin Gordon, MS; Shivali Malpotra, MS; Jack M. Moen, PhD; Ajda Rojc, MS; Atoshi Banerjee, PhD; Sourobh Maji, PhD; Monita Muralidharan, PhD; Helene Foussard, PhD; Irene P. Chen, PhD; CJ San Felipe, PhD; Lorena Zuliani-Alvarez, PhD; Promisree Choudhury, PhD; Kirsten Obernier, PhD; Rahul Suryawanshi, PhD; Taha Y. Taha, PhD, PharmD; Kliment A. Verba, PhD; James S. Fraser, PhD; Robert M. Stroud, PhD, MA; Melanie Ott, MD, PhD; Ben Polacco, PhD; Danielle L. Swaney, PhD; Ignacia Echeverria, PhD; and Manon Eckhardt, PhD. For all authors see the paper.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]















